HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $2,126,000 | -23.4% | 131,183 | 0.0% | 0.07% | -25.5% |
Q4 2020 | $2,776,000 | +42.8% | 131,183 | 0.0% | 0.10% | +34.2% |
Q3 2020 | $1,944,000 | +0.7% | 131,183 | 0.0% | 0.07% | 0.0% |
Q2 2020 | $1,930,000 | +25.3% | 131,183 | 0.0% | 0.07% | +4.3% |
Q1 2020 | $1,540,000 | +9.5% | 131,183 | +119.2% | 0.07% | +32.1% |
Q4 2019 | $1,406,000 | -84.2% | 59,842 | -87.8% | 0.05% | -85.4% |
Q2 2016 | $8,886,000 | +113.7% | 492,303 | +124.8% | 0.36% | +105.1% |
Q1 2016 | $4,159,000 | -28.9% | 219,000 | 0.0% | 0.18% | -16.5% |
Q4 2015 | $5,847,000 | +9.4% | 219,000 | 0.0% | 0.21% | +10.4% |
Q3 2015 | $5,344,000 | -60.8% | 219,000 | -49.9% | 0.19% | -61.1% |
Q2 2015 | $13,616,000 | +7.1% | 436,970 | -50.0% | 0.49% | -2.2% |
Q1 2015 | $12,716,000 | +44.6% | 873,940 | 0.0% | 0.50% | +22.3% |
Q4 2014 | $8,792,000 | +20.8% | 873,940 | 0.0% | 0.41% | +20.8% |
Q3 2014 | $7,280,000 | -32.4% | 873,940 | 0.0% | 0.34% | -65.5% |
Q2 2014 | $10,767,000 | +11.1% | 873,940 | +25.5% | 0.99% | +2.0% |
Q1 2014 | $9,690,000 | – | 696,597 | – | 0.97% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $783 | 100.00% |
Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
CM Management, LLC | 450,000 | $463,500 | 0.49% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |